These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33118640)

  • 1. The use of intravenous amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome.
    Ren J; Yang Y; Zhu J; Wu S; Wang J; Zhang H; Shao X
    Pacing Clin Electrophysiol; 2021 Jan; 44(1):35-43. PubMed ID: 33118640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation.
    Simonian SM; Lotfipour S; Wall C; Langdorf MI
    Intern Emerg Med; 2010 Oct; 5(5):421-6. PubMed ID: 20437113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
    Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
    Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation.
    Boriani G; Biffi M; Frabetti L; Azzolini U; Sabbatani P; Bronzetti G; Capucci A; Magnani B
    Am Heart J; 1996 Jun; 131(6):1214-6. PubMed ID: 8644602
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation.
    Cybulski J; Kułakowski P; Budaj A; Danielewicz H; Maciejewicz J; Kawka-Urbanek T; Ceremuzyński L
    Clin Cardiol; 2003 Jul; 26(7):329-35. PubMed ID: 12862299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibutilide for termination of atrial fibrillation in the Wolff-Parkinson-White syndrome.
    Varriale P; Sedighi A; Mirzaietehrane M
    Pacing Clin Electrophysiol; 1999 Aug; 22(8):1267-9. PubMed ID: 10461309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation and treatment of atrial fibrillation in Wolff-Parkinson-White syndrome.
    Thanavaro JL; Thanavaro S
    Heart Lung; 2010; 39(2):131-6. PubMed ID: 20207273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.
    Wellens HJ; Brugada P; Abdollah H
    Am Heart J; 1983 Oct; 106(4 Pt 2):876-80. PubMed ID: 6613833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome.
    Sheinman BD; Evans T
    Br Med J (Clin Res Ed); 1982 Oct; 285(6347):999-1000. PubMed ID: 6812745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome.
    Feld GK; Nademanee K; Stevenson W; Weiss J; Klitzner T; Singh BN
    Am Heart J; 1988 Jan; 115(1 Pt 1):102-7. PubMed ID: 3336964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous amiodarone in the acute termination of supraventricular arrhythmias.
    Holt P; Crick JC; Davies DW; Curry P
    Int J Cardiol; 1985 May; 8(1):67-79. PubMed ID: 3997293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of intravenously administered dofetilide in patients with Wolff-Parkinson-White syndrome.
    Krahn AD; Klein GJ; Yee R
    Pacing Clin Electrophysiol; 2001 Aug; 24(8 Pt 1):1258-60. PubMed ID: 11523612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontal plane QRS-T angle in the monitoring of intravenous amiodarone infusion for pharmacological cardioversion of acute atrial fibrillation.
    Eyuboglu M
    J Clin Pharm Ther; 2021 Jun; 46(3):731-737. PubMed ID: 33340427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral atrial function after chemical cardioversion of atrial fibrillation with amiodarone: an echo-Doppler study.
    Escudero EM; San Mauro M; Lauglé C
    J Am Soc Echocardiogr; 1998 Apr; 11(4):365-71. PubMed ID: 9571586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation.
    Koskinas KC; Fragakis N; Katritsis D; Skeberis V; Vassilikos V
    Europace; 2014 Jul; 16(7):973-9. PubMed ID: 24473502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
    Cotter G; Blatt A; Kaluski E; Metzkor-Cotter E; Koren M; Litinski I; Simantov R; Moshkovitz Y; Zaidenstein R; Peleg E; Vered Z; Golik A
    Eur Heart J; 1999 Dec; 20(24):1833-42. PubMed ID: 10581142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study.
    Bianconi L; Castro A; Dinelli M; Alboni P; Pappalardo A; Richiardi E; Santini M
    Eur Heart J; 2000 Aug; 21(15):1265-73. PubMed ID: 10924317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous amiodarone decreases the duration of atrial fibrillation associated with acute myocardial infarction.
    Kontoyannis DA; Anastasiou-Nana MI; Kontoyannis SA; Zaga AK; Nanas JN
    Cardiovasc Drugs Ther; 2001 Mar; 15(2):155-60. PubMed ID: 11669409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion.
    Opolski G; Stanisławska J; Górecki A; Swiecicka G; Torbicki A; Kraska T
    Clin Cardiol; 1997 Apr; 20(4):337-40. PubMed ID: 9098591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous amiodarone for conversion of atrial fibrillation: misled by meta-analysis?
    Slavik RS; Zed PJ
    Pharmacotherapy; 2004 Jun; 24(6):792-8. PubMed ID: 15222670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.